Labshake search
Citations for R&D Systems :
1 - 50 of 10000+ citations for 6 BROMO 4 4 DIETHYL 1H BENZO D 1 3 OXAZINE 2 4H THIONE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... OCT3/4 (1:500, R&D Systems), SMA (1:400 ...
-
bioRxiv - Immunology 2022Quote: IL-4 complexes were generated by incubating 2 μg mouse rIL-4 (R&D Systems) with 10 μg LEAF purified anti-mouse IL4 antibody (clone 11B11 ...
-
bioRxiv - Immunology 2020Quote: ... 3 and 4 were measured using Luminex technology (R&D Systems), according to the manufacturer’s protocols ...
-
bioRxiv - Immunology 2021Quote: ... After washing wells were incubated with a 5-bromo-4-chloro-3⍰-indolyl phosphate (BCIP)/nitro blue tetrazolium (NBT) substrate (R&D systems, mouse IFNγ Kit Cat # EL485). Plates were scanned and analyzed using ImmunoSpot Microanalyzer.
-
bioRxiv - Bioengineering 2022Quote: ... recombinant human interleukin 4 (IL-4) (R&D Systems), Alpha MEM with nucleosides (StemCell Technologies ...
-
bioRxiv - Cancer Biology 2021Quote: Cells were grown to 70% confluent in 24-well plates prior to treatment with N-[2-[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide dihydrochloride (H89; R&D Systems) or 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde (KNK437 ...
-
bioRxiv - Immunology 2021Quote: Recombinant CSF-1 (4 µg/dose; R&D Systems) was given to EAE mice on days 4 ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were cultured for 4 days with 3 μM CHIR (R&D Systems); 3 days with 200 ng/mL FGF9 (R&D Systems) ...
-
Low-dose cytokine immunotherapy of solid cancers enabled by phagocytic-competent protein co-crystalsbioRxiv - Cancer Biology 2023Quote: ... 3 and 6 days and subsequently tested by IL-2 ELISA (R&D Systems) according to the manufacturer’s protocol.
-
bioRxiv - Immunology 2021Quote: ... mice were injected subcutaneously with IL-4 complex (IL-4c) comprised of rmIL-4 (2 μg, R&D systems) combined with anti-IL-4 antibody 10 μg ...
-
bioRxiv - Immunology 2021Quote: ... and interleukin 4 (IL-4; 500 U/mL; R&D Systems). GM-CSF and IL-4 were replenished on day 2 and 4 ...
-
bioRxiv - Molecular Biology 2021Quote: ... goat anti-DPP-4 (1:200; R&D systems, AF1180) and rabbit anti-MERS S1 (1:200 ...
-
bioRxiv - Genomics 2021Quote: ... Polyclonal Goat Anti- Human/Mouse Oct-3/4 Antibody (R&D System, AF1759,1:20).
-
bioRxiv - Immunology 2020Quote: ... recombinant IL-4 (R&D systems), and anti-CD40 (ThermoFisher ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-4-HNE (R&D Systems) was used with an AF647 secondary antibody (Invitrogen ...
-
bioRxiv - Immunology 2021Quote: ... Interleukin 4 (IL-4) and Interferon Gamma (IFNy) from R&D Systems/Bio-Techne (R&D Systems/Bio-Techne ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 25 ng/ml bone morphogenetic protein-4 (BMP-4, R&D Systems) and 1 μM all-trans Retinoid Acid (RA ...
-
bioRxiv - Cell Biology 2022Quote: ... and 10 ng/mL bone morphogenetic protein 4 (BMP-4) (R&D System) for five days ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Developmental Biology 2021Quote: ... anti-Oct3/4 (MAB1759, R&D Systems), anti-Sox2 (S1451 ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 4-1BB (MAB9371, R&D systems) 1mg/kg was injected on days 0 and 4 through an intravenous route ...
-
bioRxiv - Immunology 2019Quote: ... CCL3/4-APC (93342, R&D Systems), GrB-APC (GB12 ...
-
bioRxiv - Microbiology 2023Quote: ... and Interleukin-4 (R&D Systems, USA) for 7 days as previously described[44] ...
-
bioRxiv - Immunology 2024Quote: ... mouse IL-4 (#DY404, R&D Systems), and mouse IL-9 (#DY409 ...
-
bioRxiv - Microbiology 2021Quote: ... ULBP-2/5/6 (65903, R&D systems), Plexin-B1 (rea728 ...
-
bioRxiv - Bioengineering 2022Quote: ... Supernatant was collected and cytokines were quantified using mouse cytokine & chemokine convenience 6-Plex kit (IL-2, IL-4, IL-5, IL-10, IFN-γ and TNF-α; # LXSAMSM-06, R&D systems) using Luminex xMAP according to manufacturers protocols.
-
bioRxiv - Neuroscience 2019Quote: ... and passaged every 4-6 day in the presence of 5 μM ROCK inhibitor (R&D Systems) until the 4th passage (P4) ...
-
bioRxiv - Cancer Biology 2021Quote: Recombinant 52-kDa pro-cath-D (4 µM; R&D Systems) was auto-activated to 51-kDa pseudo-cath-D in 0.1 M Na-acetate buffer (pH 3.5) ...
-
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV epitopesbioRxiv - Immunology 2020Quote: ... and 1000 IU/ml of interleukin 4 (IL-4; R&D Systems, Minneapolis, MN) to differentiate them into immature dendritic cells (iDC ...
-
bioRxiv - Molecular Biology 2022Quote: Human recombinant BMP-2 and BMP-4 were purchase from R&D Systems (Minneapolis, MN). Anti-Myc and anti-HA antibodies were purchased from Cell Signaling Technology (Danvers ...
-
bioRxiv - Microbiology 2021Quote: ... 10ng/ml interleukin 4 (IL-4) and 10ng/ml transforming growth factor beta 1 (TGFβ1) (R&D systems, Minneapolis, MN), and used between days 7-9 of differentiation.
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone 63828; R&D Systems) or with the respective isotype control ...
-
bioRxiv - Microbiology 2019Quote: ... and IL-4 (6.5ng/mL; R&D Systems) for 6 days in 37°C ...
-
bioRxiv - Immunology 2019Quote: ... 50 ng/ml IL-4 (R&D Systems); 25 mM HEPES (Quality Biology ...
-
bioRxiv - Neuroscience 2020Quote: ... and sheep anti-Teneurin-4 (R&D Systems). HRP-conjugated secondary antibodies were from Thermo-Fisher.
-
bioRxiv - Immunology 2021Quote: ... IL-4 (5.0 ng/ml; R&D Systems) and/or TGF-β (2.0 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-4 (20 ng/ml; R&D Systems), IL-15 and/or IL-21 (50 ng/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... and syndecan-4 (R&D Systems Cat#: FAB291819) for 15 minutes at 4°C ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-4 (R&D Systems) and 12 ng/ml IL-10 (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... BMP-4 from R&D Systems (314-BP) was reconstituted in sterile 4 mM HCl containing 0.1% (wt/vol ...
-
bioRxiv - Immunology 2022Quote: ... and rIL-4 (0.86ng/ml, R&D Systems) for 5-6 days ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 10 mU recombinant DPP-4 (R&D Systems), or no enzyme as a control for non-enzymatic degradation over the same time period ...
-
bioRxiv - Neuroscience 2023Quote: ... 1.4 nM neurotrophin 4 (NT4, R&D systems) and 1.3 nM human insulin-like growth factor 1 (hIGF-1 ...
-
bioRxiv - Immunology 2022Quote: ... IL-4 (50 ng/ml, R&D Systems) and anti-IFN-γ (10 μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... rIL-4 (0.86 ng/mL, R&D system) and rGM-CSF (10 ng/mL ...
-
bioRxiv - Molecular Biology 2022Quote: ... 4 ng/ml WNT-3A (R&D Systems), 1 μM CHIR99021 M SB-431542 (Tocris) ...
-
bioRxiv - Molecular Biology 2023Quote: ... anti-Thrombospondin-4 (cat# AF2390; R&D Systems), and anti-TIMP-1 (cat# AF980 ...
-
bioRxiv - Pathology 2023Quote: ... Anti-4-Hydroxynonenal (R&D Systems; Biotechne, MAB3249); Anti-MUC2 (Abcam ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Thrombospondin-4 (cat# AF2390; R&D Systems), anti-TGF-β3 (cat# ab15537 ...
-
bioRxiv - Cell Biology 2023Quote: ... and platelet factor 4 (PF4, R&D Systems) were performed according to the manufacturer’s instructions ...